# FDA Approves ANDA for Micro Labs Micro Labs has received FDA approval for an abbreviated new drug application (ANDA211466), expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive pharmaceutical generics space. The approval strengthens Micro Labs' pipeline and enables the company to meet growing demand for cost-effective therapeutic alternatives.